These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1242 related articles for article (PubMed ID: 17599306)

  • 1. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea.
    Vasa CV; Glatt AE
    Am J Gastroenterol; 2003 Feb; 98(2):354-8. PubMed ID: 12591054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
    Pekova L; Shomov G; Mladenova I; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):383-6. PubMed ID: 18043555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
    Sethi AK; Al-Nassir WN; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2009 Jan; 30(1):13-7. PubMed ID: 19046063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
    Wullt M; Odenholt I
    J Antimicrob Chemother; 2004 Jul; 54(1):211-6. PubMed ID: 15163651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV; Elmer GW; Surawicz CM
    Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
    Lagrotteria D; Holmes S; Smieja M; Smaill F; Lee C
    Clin Infect Dis; 2006 Sep; 43(5):547-52. PubMed ID: 16886144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
    Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J; Routhier S; Gagnon S; Brazeau I
    Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
    Juang P; Skledar SJ; Zgheib NK; Paterson DL; Vergis EN; Shannon WD; Ansani NT; Branch RA
    Am J Infect Control; 2007 Mar; 35(2):131-7. PubMed ID: 17327194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.